Cargando…
Continuous NPWT Regulates Fibrosis in Murine Diabetic Wound Healing
Scarring is associated with significant morbidity. The mechanical signaling factor yes-associated protein (YAP) has been linked to Engrailed-1 (En1)-lineage positive fibroblasts (EPFs), a pro-scarring fibroblast lineage, establishing a connection between mechanotransduction and fibrosis. In this stu...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611271/ https://www.ncbi.nlm.nih.gov/pubmed/36297560 http://dx.doi.org/10.3390/pharmaceutics14102125 |
_version_ | 1784819484586934272 |
---|---|
author | Wu, Mengfan Matar, Dany Y. Yu, Zhen Chen, Ziyu Knoedler, Samuel Ng, Brian Darwish, Oliver A. Sohrabi, Sadaf Friedman, Leigh Haug, Valentin Murphy, George F. Rinkevich, Yuval Orgill, Dennis P. Panayi, Adriana C. |
author_facet | Wu, Mengfan Matar, Dany Y. Yu, Zhen Chen, Ziyu Knoedler, Samuel Ng, Brian Darwish, Oliver A. Sohrabi, Sadaf Friedman, Leigh Haug, Valentin Murphy, George F. Rinkevich, Yuval Orgill, Dennis P. Panayi, Adriana C. |
author_sort | Wu, Mengfan |
collection | PubMed |
description | Scarring is associated with significant morbidity. The mechanical signaling factor yes-associated protein (YAP) has been linked to Engrailed-1 (En1)-lineage positive fibroblasts (EPFs), a pro-scarring fibroblast lineage, establishing a connection between mechanotransduction and fibrosis. In this study, we investigate the impact of micromechanical forces exerted through negative pressure wound therapy (NPWT) on the pathophysiology of fibrosis. Full-thickness excisional dorsal skin wounds were created on diabetic (db/db) mice which were treated with occlusive covering (control) or NPWT (continuous, −125 mmHg, 7 days; NPWT). Analysis was performed on tissue harvested 10 days after wounding. NPWT was associated with increased YAP (p = 0.04) but decreased En1 (p = 0.0001) and CD26 (p < 0.0001). The pro-fibrotic factors Vimentin (p = 0.04), α-SMA (p = 0.04) and HSP47 (p = 0.0008) were decreased with NPWT. Fibronectin was higher (p = 0.01) and collagen deposition lower in the NPWT group (p = 0.02). NPWT increased cellular proliferation (p = 0.002) and decreased apoptosis (p = 0.03). Western blotting demonstrated increased YAP (p = 0.02) and RhoA (p = 0.03) and decreased Caspase-3 (p = 0.03) with NPWT. NPWT uncouples YAP from EPF activation, through downregulation of Caspace-3, a pro-apoptotic factor linked to keloid formation. Mechanotransduction decreases multiple pro-fibrotic factors. Through this multifactorial process, NPWT significantly decreases fibrosis and offers promising potential as a mode to improve scar appearance. |
format | Online Article Text |
id | pubmed-9611271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96112712022-10-28 Continuous NPWT Regulates Fibrosis in Murine Diabetic Wound Healing Wu, Mengfan Matar, Dany Y. Yu, Zhen Chen, Ziyu Knoedler, Samuel Ng, Brian Darwish, Oliver A. Sohrabi, Sadaf Friedman, Leigh Haug, Valentin Murphy, George F. Rinkevich, Yuval Orgill, Dennis P. Panayi, Adriana C. Pharmaceutics Article Scarring is associated with significant morbidity. The mechanical signaling factor yes-associated protein (YAP) has been linked to Engrailed-1 (En1)-lineage positive fibroblasts (EPFs), a pro-scarring fibroblast lineage, establishing a connection between mechanotransduction and fibrosis. In this study, we investigate the impact of micromechanical forces exerted through negative pressure wound therapy (NPWT) on the pathophysiology of fibrosis. Full-thickness excisional dorsal skin wounds were created on diabetic (db/db) mice which were treated with occlusive covering (control) or NPWT (continuous, −125 mmHg, 7 days; NPWT). Analysis was performed on tissue harvested 10 days after wounding. NPWT was associated with increased YAP (p = 0.04) but decreased En1 (p = 0.0001) and CD26 (p < 0.0001). The pro-fibrotic factors Vimentin (p = 0.04), α-SMA (p = 0.04) and HSP47 (p = 0.0008) were decreased with NPWT. Fibronectin was higher (p = 0.01) and collagen deposition lower in the NPWT group (p = 0.02). NPWT increased cellular proliferation (p = 0.002) and decreased apoptosis (p = 0.03). Western blotting demonstrated increased YAP (p = 0.02) and RhoA (p = 0.03) and decreased Caspase-3 (p = 0.03) with NPWT. NPWT uncouples YAP from EPF activation, through downregulation of Caspace-3, a pro-apoptotic factor linked to keloid formation. Mechanotransduction decreases multiple pro-fibrotic factors. Through this multifactorial process, NPWT significantly decreases fibrosis and offers promising potential as a mode to improve scar appearance. MDPI 2022-10-06 /pmc/articles/PMC9611271/ /pubmed/36297560 http://dx.doi.org/10.3390/pharmaceutics14102125 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wu, Mengfan Matar, Dany Y. Yu, Zhen Chen, Ziyu Knoedler, Samuel Ng, Brian Darwish, Oliver A. Sohrabi, Sadaf Friedman, Leigh Haug, Valentin Murphy, George F. Rinkevich, Yuval Orgill, Dennis P. Panayi, Adriana C. Continuous NPWT Regulates Fibrosis in Murine Diabetic Wound Healing |
title | Continuous NPWT Regulates Fibrosis in Murine Diabetic Wound Healing |
title_full | Continuous NPWT Regulates Fibrosis in Murine Diabetic Wound Healing |
title_fullStr | Continuous NPWT Regulates Fibrosis in Murine Diabetic Wound Healing |
title_full_unstemmed | Continuous NPWT Regulates Fibrosis in Murine Diabetic Wound Healing |
title_short | Continuous NPWT Regulates Fibrosis in Murine Diabetic Wound Healing |
title_sort | continuous npwt regulates fibrosis in murine diabetic wound healing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611271/ https://www.ncbi.nlm.nih.gov/pubmed/36297560 http://dx.doi.org/10.3390/pharmaceutics14102125 |
work_keys_str_mv | AT wumengfan continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT matardanyy continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT yuzhen continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT chenziyu continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT knoedlersamuel continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT ngbrian continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT darwisholivera continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT sohrabisadaf continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT friedmanleigh continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT haugvalentin continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT murphygeorgef continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT rinkevichyuval continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT orgilldennisp continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing AT panayiadrianac continuousnpwtregulatesfibrosisinmurinediabeticwoundhealing |